Description: COMPASS Pathways plc operates as a mental health care company in the United Kingdom and the United States. It develops COMP360, a psilocybin therapy that is in Phase III clinical trials for the treatment of treatment-resistant depression; and is in Phase II clinical trials for the treatment of post-traumatic stress disorder and anorexia nervosa. The company was formerly known as COMPASS Rx Limited and changed its name to COMPASS Pathways plc in August 2020. COMPASS Pathways plc was incorporated in 2020 and is headquartered in London, the United Kingdom.
Home Page: compasspathways.com
33 Broadwick Street
London,
W1F 0DQ
United Kingdom
Phone:
44 71 6676 6461
Officers
| Name | Title |
|---|---|
| Mr. Kabir Kumar Nath M.A., M.B.A. | CEO & Director |
| Mr. Matthew Allen Owens | General Counsel & Chief Legal Officer |
| Dr. Guy Goodwin | Chief Medical Officer |
| Ms. Teri Loxam M.B.A. | CFO, Principal Financial Officer & Principal Accounting Officer |
| Dr. Greg Ryslik Ph.D. | Chief Technology Officer |
| Mr. Stephen D. Schultz | Senior Vice President of Investor Relations |
| Mr. Christopher Williams | Chief Communications Officer |
| Ms. Anne Benedict | Chief People Officer |
| Mr. Lars Christian Wilde | Senior Advisor |
| Dr. Susan C. Stansfield Ph.D. | Advisor |
Exchange: F
Country: DE : Germany
Currency: Euro (€)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Health Care Equipment & Services |
| GIC Industry: | Health Care Providers & Services |
| GIC Sub-Industry: | Health Care Facilities |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 1.3883 |
| Price-to-Sales TTM: | 0 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 186 |